SS
RXST icon

Steve Schonfeld’s RxSight RXST Stock Holding History

Steve Schonfeld’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.38M Buy
701,417
+509,717
+266% +$3.08M 0.01% 803
2026
Q1 		$1.18M Sell
191,700
-26,975
-12% -$224K 0.01% 1013
2025
Q4 		$2.28M Sell
218,675
-338,926
-61% -$3.4M 0.01% 828
2025
Q3 		$5.01M Buy
557,601
+292,595
+110% +$2.57M 0.03% 589
2025
Q2 		$3.45M Buy
265,006
+100,037
+61% +$1.5M 0.02% 716
2025
Q1 		$4.17M Sell
164,969
-34,431
-17% -$1.02M 0.03% 589
2024
Q4 		$6.86M Buy
+199,400
New +$8.99M 0.04% 408
2024
Q3 		– Sell
-48,004
Closed -$2.89M – 2371
2024
Q2 		$2.89M Sell
48,004
-116,102
-71% -$6.63M 0.02% 747
2024
Q1 		$8.46M Sell
164,106
-24,789
-13% -$1.22M 0.06% 438
2023
Q4 		$7.62M Buy
188,895
+79,995
+73% +$2.35M 0.05% 421
2023
Q3 		$3.04M Sell
108,900
-38,000
-26% -$1.13M 0.02% 697
2023
Q2 		$4.23M Buy
146,900
+23,500
+19% +$523K 0.04% 535
2023
Q1 		$2.06M Buy
123,400
+75,600
+158% +$1.07M 0.02% 678
2022
Q4 		$606K Buy
+47,800
New +$581K 0.01% 1424

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Steve Schonfeld's RXST Position: Q2 2026 in Review

Steve Schonfeld increased its RxSight (RXST) stake by 266% in Q2 2026, buying an estimated $3.08M and bringing the position to 701,417 shares worth $3.38M. The position accounts for 0.01% of the portfolio, ranked #803.

Steve Schonfeld first reported a position in RXST in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.46M in Q1 2024. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Steve Schonfeld held 701,417 shares of RxSight worth $3.38M as of Q2 2026.
  • Steve Schonfeld bought 509,717 RxSight shares in Q2 2026, an estimated $3.08M.
  • RxSight made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #803 holding.
  • Steve Schonfeld first reported a position in RxSight in Q4 2022 and has held it in 14 quarters since.
  • Steve Schonfeld's RxSight position peaked at $8.46M in Q1 2024.
  • 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.